Cardiovascular Magnetic Resonance Late Gadolinium Enhancement Risk Score for Mortality in Patients with Hypertrophic Cardiomyopathy: the HCM-LGE Risk Score | Synapse
March 3, 2026Open Access
Cardiovascular Magnetic Resonance Late Gadolinium Enhancement Risk Score for Mortality in Patients with Hypertrophic Cardiomyopathy: the HCM-LGE Risk Score
Key Points
Mortality appears correlated with the gadolinium enhancement risk score in hypertrophic cardiomyopathy patients, indicating clinical significance.
The study identifies specific metrics that enhance understanding of mortality risks, with implications for patient care.
Assessment using cardiovascular magnetic resonance data offers insights into hypertrophic cardiomyopathy risk profiles for better prognosis.
Further validation needed as findings are based on observational analysis; additional research can clarify broader applicability.